Skip to main content
SpringerLink
Log in

Alosetron

A Viewpoint by Michael J. Ford

  • Adis New Drug Profile
  • Guest Commentary
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Gershon, MD. Roles played by 5-hydroxytryptamine in the physiology of the bowel. Aliment Pharmacol Ther 1999; 13 Suppl. 2: 15–30

    PubMed  Google Scholar 

  2. Camilleri M, Saslow SB, Bharucha AE. Gastrointestinal sensation — mechanisms and relation to functional gastrointestinal disorders. Gastroenterol Clin North Am 1996; 25: 247–258

    Article  PubMed  CAS  Google Scholar 

  3. Drossman DA, Creed FH, Olden KW, et al. Psychosocial aspects of the functional gastrointestinal disorders. Gut 1999; 45 Suppl. 2: II25–30

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Western General Hospital, Edinburgh, Scotland

    Michael J. Ford

Authors
  1. Michael J. Ford
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ford, M.J. Alosetron. Drugs 59, 519–520 (2000). https://doi.org/10.2165/00003495-200059030-00011

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-200059030-00011

Search

Navigation